Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Similar documents
Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

CMP: INR121 TP: INR193 Buy

Unitech. CMP: INR20 TP: INR30 Buy

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Reliance Infrastructure CMP: INR528

Godawari Power & Ispat

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Jaiprakash Associates

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Canara Bank. CMP: INR419 TP: INR525 Buy

IDBI Bank. CMP: INR106 TP: INR121 Neutral

BGR Energy. CMP: INR284 TP: INR296 Neutral

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy

Sanjay Jain Pavas Pethia

NTPC CMP: INR169 TP: INR191 Buy

Hardick Bora

Idea Cellular. CMP: INR81 TP: INR Under Review

Titan Industries. CMP: INR222 TP: INR220 Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

BGR Energy. CMP: INR266 TP: INR230 Neutral

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral

Coal India CMP: INR348 TP: INR408 Buy

Tata Power. CMP: INR111 TP: INR92 Neutral

Godrej Consumer Products

Hindalco. CMP: INR113 TP: INR151 Buy

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

Niket Shah

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Petronet LNG. CMP: INR146 TP: INR205 Buy

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Dabur India. CMP: INR106 TP: INR94 Neutral

Sohail Halai Alpesh Mehta

Jinesh Gandhi Sandipan Pal

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Tribhovandas Bhimji Zaveri

CMP: INR350 TP: INR375 Downgrade to Neutral

Steel Authority of India

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

CMP: INR415 TP: INR 471 BUY

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

Strides Arcolab. CMP: INR717 TP: INR829 Buy

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Stress test: Weak capital servicing ratios to drive pricing discipline

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Godrej Properties. CMP: INR595 TP: INR635 Neutral

Birla Corporation. CMP: INR216 TP: INR277 Buy

Jinesh Gandhi Chirag Jain

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

M&M Financial Services

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Idea Cellular. CMP: INR159 TP: INR200 Buy

Thermax. CMP: INR522 TP: INR414 Neutral

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Godrej Consumer Products

Phoenix Mills. CMP: INR184 TP: INR255 Buy

Oberoi Realty. CMP: INR269 TP: INR320 Buy

Dabur India. CMP: INR130 TP: INR135 Neutral

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

Siddharth Bothra

Urban demand revives; Akzo gaining market share

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008

Market share recovery, price hike, content leverage to drive growth

BHEL. CMP: INR227 TP: INR233 Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Cross service charges at INR m/quarter

Coal India. CMP: INR322 TP: INR370 Buy

ITC. CMP: INR201 TP: INR230 Buy

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Jinesh Gandhi Sandipan Pal

Godrej Consumer Products

Reliance Communications

Jinesh Gandhi Sandipan Pal

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Jinesh Gandhi Chirag Jain

Dabur India. Neutral. Rs93

Previous Recommendation: Buy

Alpesh Mehta Sohail Halai

Shriram Transport Finance

Godrej Consumer Products

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

CPCB-2: Important long-term driver

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Torrent Pharmaceuticals

Previous Recommendation: Neutral

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Transcription:

BSE SENSEX S&P CNX 18,202 5,532 Bloomberg SHRS IN Equity Shares (m) 671.0 52-Week Range (INR) 87/23 1,6,12 Rel. Perf. (%) 14/-39/-51 M.Cap. (INR b) 27.3 M.Cap. (USD b) 0.6 16 February 2012 5QSY12 Results Update Sector: Sugar CMP: INR41 TP: INR50 Buy ' (SHRS) reported 11% YoY growth in EBIDTA to INR3.3b for 5QFY12 (change in accounting year to April-March from October-September). Revenue declined 9% YoY to INR20.5b, while PAT surged 4x to INR3.4b due to forex gain of INR4.3b on USD/Real dominated liabilities. The forex gain was due to adoption of revised accounting standard to amortize change in long term foreign exchange liabilities over the tenor of the liability. Standalone EBITDA slipped by just 3% YoY, despite the huge 37% YoY decline in revenue (on account of lower sugar sales and trading revenue). Expansion in EBITDA margin is attributed to the improvement in realizations across all segments. The company expects its refinery business to improve over next couple of quarters due to (1) favorable sugar spread; and (2) substantial availability of domestic raw sugar. In Brazil, numbers remained steady on a YoY basis, although margins improved on account of higher sugar realization. However, higher realization was offset by lower volumes on account of adverse weather that impacted crushing volume of Renuka do Brasil (RDB). After the severe impact on cane yield in 4QSY11, the management expects yields to recover to ~65t/ha going forward. During 5QFY12, SHRS has achieved its plantation target of ~25,000 ha (20,045ha at RDB and 5,136ha at VDI). We expect re-plantation to lower average age of crops and improve productivity/yield. The company's net debt increased by ~INR7b to ~INR90b due to the increase in working capital debt in Indian operations. The management guided the divestment of co-gen business (138MW at Equipav) to be concluded by Feb-end. We believe this event would be a key trigger for the company's re-capitalization target. Going forward, key triggers for the stock's would be: (1) turnaround in volumes and cane yield of its Brazilian operations, (2) upswing in international sugar prices, and (3) reduction in debt. The stock trades at 5.8x FY13E EPS of INR7, and EV/EBITDA of 5.2x FY13E. We continue to value SHRS at 6x EV/ EBITDA, leading to a lower target price of INR50. Maintain Buy. Sandipan Pal (Sandipan.Pal@MotilalOswal.com); Tel: +91 22 3982 5436

Geographic composition Sales mix: Domestic 43% (56% in 4Q) and Brazil 57% (44% in 4Q). EBITDA mix: Domestic 31% (22% in 4Q) and Brazil 69% (78% in 4Q). Crushing: Total crushing dropped by 17%QoQ and 33% YoY to 3mt. The decline is largely attributed to the ~56% volume drop of the company's Brazil operations due to adverse weather impacting crop yield. India operations commenced the new crushing season with a 5% YoY jump in crushing. Lower crushing also led to ~44% YoY drop in sugar production in Brazil. Geographical Sales Mix (INR m) India Brazil 5QFY12 1QFY12 Chg.(YoY) 4QFY12 Chg.(QoQ) 5QFY12 1QFY12 Chg.(YoY) 4QFY12 Chg.(QoQ) Net Sales 6,975 11,115-37 11,363-38.6 9,086 9,046 0 9,098-0.1 EBITDA 1,058 1,087-3 609 73.7 2,320 2,081 11 2,157 7.6 EBITDA (%) 15 10 55 5 183.0 26 25 0 24 7.7 Foreign exchange 342 3,952 298 (5,558) PAT 291 304-4 (573) -150.8 2,993 308 872 (6,452) -146.4 Sales proportion (%) 43 55 56 57 45 44 EBITDA proportion (%) 31 34 22 69 66 78 Source: Company/MOSL Crushing mix (mt) Production mix (mt) Source: Company/MOSL Key operating metrics: Domestic Business 1QSY11 2QSY11 3QSY11 4QSY11 5QFY12 YoY (%) Sugarcane Crushed (t) 1,674,090 2,803,472 748,680-1,759,303 5 Raw Sugar Processed (t) 120,813 69,770 70,750 117,828 81,685 (32) Recovery (%) 10.4 12.2 12.1-11.0 5.8 Sugar From Cane (t) 167,301 342,958 90,758-192,724 15 - Raw Sugar (t) - White Sugar (t) 167,301 342,958 90,758-192,724 15 Refined Sugar (t) 114,039 67,080 66,980 110,921 78,417 (31) Total Sugar Produced 281,340 410,038 157,738 110,921 271,141 (4) Ethanol Production (KL) 17,594 42,952 40,852 9,019 25,094 43 Realization (INR/Ltr) 28 28 27 29 29 4 Co-generation Exports (mm units) 108 150 81 19 79 (27) Realizations (INR/Unit) 3.8 5.4 6.4 3.5 4.5 17.0 16 February 2012 2

Key operating metrics: Brazil Business 1QSY11 2QSY11 3QSY11 4QSY11 5QFY12 YoY (%) Sugarcane Crushed (t) 2,779,552 170,662 3,359,838 3,600,790 1,229,294 (56) Raw Sugar Processed (t) - - - - Recovery (%) 129.7 106 117 138 134 3.1 Sugar From Cane (t) 165,996 6,790 167,124 289,075 93,201 (44) - Raw Sugar (t) 157,576 6,790 113,336 289,075 93,076 - White Sugar (t) 8,420-53,788-125 (99) Refined Sugar (t) - - - - Total Sugar Produced 165,996 6,790 167,124 289,075 93,201 (44) Ethanol Production (KL) 111,817 8,548 129,519 118,210 39,561 (65) Realization (INR/Ltr) 32 38.1 47 37 35 9 Co-generation Exports (mm units) 120 40.0 95 123 187 56 Realizations (INR/Unit) 4.6 4.5 4.1 4.1 4.3 (6.9) India operations: New crushing season commenced Sales declined 38% QoQ (-37% YoY) to INR7b driven by decline in sugar sales and trading revenue. Sugar sales dropped due to lower utilization of refinery on the back of unfavorable white-raw spread. EBIDTA margin expanded strongly to 15.2% from 9.8% in 1QSY12 due to improvement in realizations across segments. Crushing improved 5% YoY to 1.8mt; Recovery improved to 11% v/s 10.4% in 1QSY11. Sugar segment: EBIT margin improved to 9.8% from 9.1% in 1QSY12 and 2.8% in 4QSY11. The QoQ improvement is due to seasonal impact. Production declined 4% YoY to 0.27mt due to lower refinery volume on the back of unfavorable white-raw spread. Refinery volume stood at 0.08mt v/s 0.11mt in 4QSY11 and 1QSY11 against a capacity of 9,000t/day. Sugar sales volumes dropped 45% YoY to 1.6mt. Blended realizations declined 4% QoQ (flat YoY) to INR28.4/kg, due to lower proportion of export sales in sugar. Ethanol segment: Volumes increased 14% YoY and realizations rose 4% YoY; EBIT margin rose to 28.5% from 16.9% in 1QSY11. Ethanol blending program continues to drive demand. However, sales to oil marketing companies (OMCs) declined to 6ml v/s 18.8ml in 4QSY11. SHRS has received orders for the supply of 75ml to OMCs during the year Oct-11 to Sep- 12. Average ethanol realization in 5QFY12 was INR28.9/l (v/s INR29.1/l in 4QSY11). The company believes the proposal of linking ethanol price with domestic petrol prices is likely to boost realizations. The management also mentioned that given the current shortage of ethanol, world market could be supportive of ethanol exports in the near-term. 16 February 2012 3

Co-generation: Volumes declined 27% YoY and realization increased 17% YoY; EBIT margin rose to 45.5% v/s 8% 1QSY11. Volumes fell to 70m units due to the lower utilization of the refineries and delayed crushing. Realization improved QoQ to INR4.5/unit. Operating margin improved due to lower cost of fuel, primarily as the company used its own bagasse. Sugar sales declined due to lower Lower export sales dented average QoQ movement of export and domestic refinery volume realization QoQ (mt) sugar prices Ethanol volume up YoY, QoQ performance in co-generation, Refinery volume (mt) impacted due so is realization realization up sharply to lower utilization Raw and White sugar price trend White-raw spread was unfavorable Domestic sugar price has been between (USD/t) (USD/t) INR2,800-3,300/quintal Source: Company/MOSL 16 February 2012 4

Standalone segmental performance Y/E September FY11 FY12 QoQ YoY INR m 1Q 2Q 3Q 4Q 1Q (%) (%) Sugar 8,368 6,981 8,493 5,994 4,517 (25) (46) Cogeneration 725 1,363 877 407 692 70 (5) Trading 2,085 4,274 1,931 4,166 1,984 (52) (5) Ethanol 378 910 895 1,087 452 (58) 20 Others 6 17 30 10 7 (30) 17 Total 11,562 13,545 12,226 11,664 7,652 (34) (34) Less: Intersegment Rev. 548 1,056 154 391 682 74 24 Total Revenue 11,014 12,489 12,072 11,273 6,970 (38) (37) Segmental PBIT Sugar 758 341 459 169 442 162 (42) Cogeneration 58 679 382 (15) 314 LTP 441 Trading 51 181 88 65 67 3 31 Ethanol 64 237 395 186 129 (31) 102 Others (1) (5) 27 5 (1) (120) - Total 930 1,433 1,351 410 951 132 2 Segmental PBIT Margin (%) Sugar 9.1 4.9 5.4 2.8 9.8 Cogeneration 8.0 49.8 43.6 (3.7) 45.4 Trading 2.4 4.2 4.6 1.6 3.4 Ethanol 16.9 26.0 44.1 17.1 28.5 Brazilian operation: End of crushing season Sales and EBITDA steady: Sales during the quarter were flat at INR9.1b, while EBITDA improved 11% YoY. Sales comprise (a) INR6.4b (down 15%YoY) from Renuka do Brasil (RDB) and (b) INR2.7b (up 67%YoY) from Vale do Ivai (VDI). EBITDA margin improves: EBIDTA margin was 25% v/s 25% in 1QSY11; RDB's EBITDA margin contracted to 23% from 25% in 1QSY11 due to adverse weather which resulted in a sharp drop in yield in Sao Paulo state. VDI's margin improved to 32% from 24% in 1QSY11. Crushing was impacted due to adverse weather conditions (drought in Sao Paulo state) with total crushing of 8.3mt (6mt in RDB and 2.3mt in VDI) over last season, including 1.2mt in 5QFY12 v/s 2.8mt in 1QSY11 (56% YoY decline). Recovery improves: ATR was 133.7kg/t v/s 129.7kg/t in 1QSY11 and 138kg/t in 4QSY11. With better sugar prices, higher proportion (58.7%) of juice was diverted towards sugar production (v/s 48.3% for the industry). Planting target achieved: During 5QFY12, the company achieved its plantation target of ~25,000 ha (20,045 ha at RDB and 5,136 ha at VDI). We expect this to lower the average age of its crops and improve productivity/yield for next crushing season. Sugar realizations down QoQ at 24.4c/lb: The company achieved average sales price of 24.4c/lb (hedged floor price of 23c/lb) v/s 26c/lb in 4QSY11 on 0.18mt sold during the quarter. YoY improvement in sugar realization (~37%) was offset by lower volumes. 16 February 2012 5

Brazilian Subsidiary Performance (INR m) Renuka do Brasil Vale do Ivai Brazil Operations 5QFY12 1QFY12 Chg. (YoY) 5QFY12 1QFY12 Chg. (YoY) Consolidated Net Revenue 6,379 7,535-15.3 2,707 1,624 66.7 9,086 EBITDA 1,466 1,902-22.9 860 391 119.9 2,326 % EBITDA 23.0 25.2-9.0 31.8 24.1 32.0 25.6 PAT 2,117 54 3820.4 893 192 365.1 2,993 Management's outlook and guidance: Expect high production phase in India nearing end; co-gen divestment to conclude soon Focus remains on reviving Brazilian operation and de-leveraging. Near-term sugar pricing outlook is range-bound on account of higher beet sugar production in Europe and surplus sugar production in India and Thailand. Despite higher volumes, pricing outlook to remain strong due to (a) re-stocking demand from major importing countries, (b) strong unmet ethanol (flexi-fuel car) demand in Brazil; and (c) lack of sustainability of European sugar production in a low-price scenario given average cost of production of ~25c/lb Divestment of co-gen business (138MW at Equipav) is likely to be concluded by Feb-end. We believe this to be a key trigger for de-leveraging target. RDB is expected to operate at 65t/ha yield for going forward. Indian operations have registered the best- ever recovery rate and could touch ~12% in the current crushing season against 11.5%. Refinery vertical to see USD60/ton of EBITDA based on current spread. Domestic raw sugar availability renders strong visibility of refinery production of ~0.5mt over next couple of quarters. Indian sugar cycle is expected to see high production phase, given a) arrear building in north India and b) cane area in South India and Maharashtra being saturated with availability of water, lowering the likelihood of area increase. Valuation and view: Progress in co-gen divestment and turnaround in Brazil operations are the key catalyst SHRS is the only sugar/ethanol producer in the world with almost year-long cane crushing activity as it has operations in Brazil and India, which have complementary crushing seasons. This allows it to: (1) manage inventory, (2) benefit from price arbitrage between sugar/ethanol, raw/white sugar, (3) play price arbitrage between India's regulated sugar industry and liquid global markets, and (4) leverage synergies, and offer steady returns despite cyclical nature of the industry. Adverse weather that impacted production volume and margins at its Brazilian operations, coupled with lower production expectation in refinery business, have taken a huge toll on the stock performance post 4QSY11. Its high leverage level also remains a huge near-term overhang on the stock. However, going forward, we believe with (a) progress in co-gen divestment (a trigger for de-leveraging), (b) re-plantation improving productivity/yield in Brazilian subsidiaries, (c) robust domestic outlook, the stock could see meaningful upside. The stock trades at 5.8x FY13E EPS of INR7, and EV/EBITDA of 5.2x FY13E. We continue to value SHRS at 6x EV/EBITDA, leading to a lower target price of INR50. Maintain Buy. 16 February 2012 6

Shareholding pattern (%) Dec-11 Sep-11 Dec-10 Promoter 38.1 38.1 37.9 Domestic Inst 14.3 6.9 11.1 Foreign 18.7 27.6 23.4 Others 29.0 27.5 27.6 Stock performance (1 year) Shree Renuka Sug 100 80 60 40 Sensex - Rebased 20 Feb-11 Ma y-11 Aug-11 Nov-11 Feb-12 16 February 2012 7

Financials and Valuation 16 February 2012 8

N O T E S 16 February 2012 9

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. MOSt is not a registered broker-dealer in the United States (U.S.) and, therefore, is not subject to U.S. rules. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., Motilal Oswal has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, Marco Polo and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. Motilal Oswal Securities Ltd 3rd Floor, Hoechst House, Nariman Point, Mumbai 400 021 Phone: (91-22) 39825500 Fax: (91-22) 22885038. E-mail: reports@motilaloswal.com